Return to Trial Database

HCRN-BSK22-562

Observational basket trial to predict response to immune checkpoint inhibitors across solid tumors using a live tumor diagnostic platform (CYBRID-02)

Status

Currently Enrolling

Cancer Type(s)

Study Contact

studies@hoosiercancer.org

Trial Locations

All sites in which the trial HCRN-BSK22-562 being conducted in.

AdventHealth Orlando

Cleveland Clinic Cancer Center

John Theurer Cancer Center at Hackensack Meridian Health

Meritus Center for Clinical Research / John R. Marsh Cancer Center

Salinas Valley Health

University of Louisville / James Graham Brown Cancer Center

University of North Carolina Lineberger Comprehensive Cancer Center

University of South Florida

University of Wisconsin Carbone Cancer Center